Get the Stockscreener App
0.4072
1.04%
0.0042
Clearside Biomedical Inc stock is traded at $0.4072, with a volume of 362.37K.
It is up +1.04% in the last 24 hours and up +15.88% over the past month.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
See More
Previous Close:
$0.403
Open:
$0.3999
24h Volume:
362.37K
Relative Volume:
0.37
Market Cap:
$31.97M
Revenue:
$4.17M
Net Income/Loss:
$-27.71M
P/E Ratio:
-1.1005
EPS:
-0.37
Net Cash Flow:
$-22.23M
1W Performance:
-3.74%
1M Performance:
+15.88%
6M Performance:
-57.14%
1Y Performance:
-59.68%
1-Day Range:
$0.3999
$0.4268
1-Week Range:
$0.391
$0.439
52-Week Range:
$0.292
$1.65
Clearside Biomedical Inc Stock (CLSD) Company Profile
Name
Clearside Biomedical Inc
Sector
Industry
Phone
678-270-3631
Address
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Compare CLSD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
0.4072 | 33.44M | 4.17M | -27.71M | -22.23M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-18-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-18-25 | Downgrade | Stifel | Buy → Hold |
| Aug-21-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-25-24 | Initiated | Oppenheimer | Outperform |
| Dec-15-21 | Resumed | Wedbush | Outperform |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| May-13-20 | Initiated | ROTH Capital | Buy |
| Aug-09-19 | Downgrade | Needham | Buy → Hold |
| Nov-05-18 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-05-18 | Downgrade | JP Morgan | Overweight → Underweight |
| Nov-05-18 | Downgrade | Stifel | Buy → Hold |
| Mar-06-18 | Reiterated | Needham | Buy |
| May-25-17 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-17 | Initiated | JP Morgan | Overweight |
| Nov-10-16 | Reiterated | Needham | Buy |
| Oct-24-16 | Reiterated | Stifel | Buy |
View All
Clearside Biomedical Inc Stock (CLSD) Latest News
Trendlines Converge — Decision Point for Clearside Biomedical Inc.Trade Entry Summary & Expert Curated Trade Setups - thegnnews.com
Clearside Biomedical Q2 2025 Earnings Misses Market Expectations, Triggering Negative Stock Reaction - AInvest
Published on: 2025-08-19 10:02:33 - 선데이타임즈
Clearside Biomedical Announces New Chairperson Appointment - MSN
Bullish Divergence Spotted in Clearside Biomedical Inc. Momentum2025 Top Gainers & AI Enhanced Trading Signals - sundaytimes.kr
Clearside Biomedical Inc. Consolidation Zone May Signal AccumulationWeekly Earnings Recap & Smart Swing Trading Techniques - beatles.ru
Clearside Biomedical Faces Delisting Risk and Names New Chairperson - AInvest
Clearside Biomedical Reports Strong Sales Growth Amid Mixed Financial Indicators in June 2025 - MarketsMojo
Is This a Bottoming Phase for Clearside Biomedical Inc.July 2025 Breakouts & Scalable Portfolio Growth Ideas - thegnnews.com
Sector ETF Data Correlates with Strength in Clearside Biomedical Inc.Quarterly Portfolio Review & Intraday High Probability Alerts - metal.it
Clearside Biomedical earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada
Clearside Biomedical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Clearside Biomedical Inc. trending in predictive chart modelsFree Growth Focused Entry Plan Suggestions - Newser
Chart based exit strategy for Clearside Biomedical Inc.Smart Safety Strategy With Real Data Analysis - Newser
Applying chart zones and confluence areas to Clearside Biomedical Inc.Weekly Return Plan for Conservative Traders - Newser
How Clearside Biomedical Inc. stock performs during market volatilityFree Triple Digit Growth Focused Trade Plan - Newser
Clearside Biomedical 2025 Q2 Earnings Narrowed Losses Amid Strong Revenue Surge - AInvest
Clearside Biomedical's Liquidity Crisis and Strategic Overhaul: A High-Risk Bet or a Path to Renewal? - AInvest
Clearside Biomedical CLSD 2025Q2 Earnings Preview Upside Potential on Strategic Collaborations - AInvest
Clearside Biomedical Q2 Earnings: Revenue Beats Estimates, Shares Down 59.7% YTD - AInvest
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Clearside Biomedical Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Using data tools to time your Clearside Biomedical Inc. exitFree Low Volatility Stable Growth Picks - Newser
Clearside Biomedical Inc. stock prediction for this weekFree AI Driven Stock Trend Forecast - Newser
Custom watchlist performance reports with Clearside Biomedical Inc.Profit Target Planning with Exit Confidence - Newser
What makes Clearside Biomedical Inc. stock price move sharplyTrade Flow Monitor with Volume Tracker - Newser
Clearside Biomedical shares fall 2.17% intraday as Piper Sandler Companies acquires G Squared Capital Partners. - AInvest
Elliott Wave Theory Predicts Pullback in Clearside Biomedical Inc.Low Volatility Stable Growth Picks Rank High - metal.it
Published on: 2025-08-04 17:07:21 - metal.it
What analysts say about Clearside Biomedical Inc. stockExceptional gains - Jammu Links News
Is Clearside Biomedical Inc. a growth stock or a value stockUnlock powerful market trend analysis - Jammu Links News
Is it the right time to buy Clearside Biomedical Inc. stockUnlock powerful stock screening for profits - Jammu Links News
Why is Clearside Biomedical Inc. stock attracting strong analyst attentionBuild a diversified portfolio for risk mitigation - Jammu Links News
Is Clearside Biomedical Inc. stock overvalued or undervaluedInvest smarter with daily market updates - Jammu Links News
What are the latest earnings results for Clearside Biomedical Inc.Rapid growth opportunities - Jammu Links News
Does Clearside Biomedical Inc. stock perform well during market downturnsUnstoppable trading performance - Jammu Links News
How does Clearside Biomedical Inc. generate profit in a changing economyGet professional advice for market timing - Jammu Links News
When is Clearside Biomedical Inc. stock expected to show significant growthUnlock daily market insights for better decisions - Jammu Links News
How volatile is Clearside Biomedical Inc. stock compared to the marketSuperior trading gains - Jammu Links News
Should I hold or sell Clearside Biomedical Inc. stock in 2025Free Popular Stock Recommendations - Jammu Links News
How does Clearside Biomedical Inc. compare to its industry peersBuild wealth faster with disciplined trading - Jammu Links News
What are Clearside Biomedical Inc. company’s key revenue driversGet timely alerts on market movers - Jammu Links News
How Resilient Is Clearside Biomedical Inc. Stock During Economic DownturnsStock Entry Point Planner with Volume Spike - Newser
Clearside Biomedical Inc. Added to High Probability Setup ListChart Driven High Reward Trading Setup Presented - beatles.ru
Strategies to average down on Clearside Biomedical Inc.Market Stability and Long-Term Growth Outlook - Newser
Competitive Positioning of Clearside Biomedical Inc.: Is It Leading or LaggingEquity Market Return Forecast Model Update - Newser
Chart overlay techniques for tracking Clearside Biomedical Inc.Sector-Wise Equity Performance Trend Forecast - Newser
Advanced analytics toolkit walkthrough for Clearside Biomedical Inc.Triple Digit Gain Opportunity Watchlist - Newser
Automated trading signals detected on Clearside Biomedical Inc.Free Smart Allocation Stock Pick Insights - Newser
Clearside Biomedical Inc. stock outlook for YEARSwing Entry Risk Mitigation with Chart Analysis - Newser
Clearside Biomedical Inc Stock (CLSD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clearside Biomedical Inc Stock (CLSD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chong Ngai Hang Victor | Chief Medical Officer |
Nov 01 '24 |
Buy |
1.00 |
36,500 |
36,500 |
100,000 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):